Evidence map›Paper›PMID 27091986›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Tissue-specific DNA demethylation is required for proper B-cell differentiation and function.

Shari Orlanski, Verena Labi, Yitzhak Reizel, Adam Spiro, Michal Lichtenstein, Rena Levin-Klein, Sergei B Koralov, Yael Skversky, Klaus Rajewsky, Howard Cedar and 1 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Methylation of T and B Lymphocytes in Autoimmune Rheumatic Diseases.Clinical reviews in allergy & immunology · 2024
    Review
  14. Hepatocyte regeneration is driven by embryo-like DNA methylation reprogramming.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Shari OrlanskiDepartment of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem, Israel 91120;
Verena LabiMax-Delbrück Center for Molecular Medicine, Berlin 13092, Germany; Division of Developmental Immunology, Biocenter, Medical University Innsbruck, Innsbruck 6020, Austria;
Yitzhak ReizelDepartment of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem, Israel 91120;
Adam SpiroDepartment of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem, Israel 91120;
Michal LichtensteinDepartment of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem, Israel 91120;
Rena Levin-KleinDepartment of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem, Israel 91120;
Sergei B KoralovDepartment of Pathology, New York University Medical Center, New York, NY 10016.
Yael SkverskyDepartment of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem, Israel 91120;
Klaus RajewskyMax-Delbrück Center for Molecular Medicine, Berlin 13092, Germany; klaus.rajewsky@mdc-berlin.de yehuditb@ekmd.huji.ac.il.
Howard CedarDepartment of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem, Israel 91120;
Yehudit BergmanDepartment of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem, Israel 91120; klaus.rajewsky@mdc-berlin.de yehuditb@ekmd.huji.ac.il.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is ample evidence that somatic cell differentiation during development is accompanied by extensive DNA demethylation of specific sites that vary between cell types. Although the mechanism of this process has not yet been elucidated, it is likely to involve the conversion of 5mC to 5hmC by Tet enzymes. We show that a Tet2/Tet3 conditional knockout at early stages of B-cell development largely prevents lineage-specific programmed demethylation events. This lack of demethylation affects the expression of nearby B-cell lineage genes by impairing enhancer activity, thus causing defects in B-cell differentiation and function. Thus, tissue-specific DNA demethylation appears to be necessary for proper somatic cell development in vivo.

Indexed as

AnimalsB-LymphocytesCell DifferentiationCells, CulturedDNA-Binding ProteinsDNA MethylationEpigenesis, GeneticMiceMice, Inbred C57BLOrgan SpecificityDNA-Binding Proteinschromatindifferentially methylated regionsDMRsTet2/Tet3

Identifiers

PMID27091986
PMCPMC4983829

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.